Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Vaylet

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Revue De Pneumologie Clinique|February 9, 2005
[The risk of thromboembolism in airline passengers]J Margery, A Bonnichon, K Hardy, et al.
Revue De Pneumologie Clinique|November 3, 2009
[Pleuro-pulmonary manifestations disclosing hepatic amoebiasis]A Bonnichon, E Henninot, A Niang, et al.
Revue Des Maladies Respiratoires|February 12, 2010
[Pulmonary malignant melanoma: primary or metastatic?]F Rivière, A Bonnichon-Py, H Le Floch, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 10, 2001
[A revolution in pneumology: positron-emission tomography]F Vaylet, O de Dreuille, P Maszelin, et al.
La Revue De Medecine Interne|January 1, 1996
[Value of video-assisted thoracic surgery in internal medicine. Apropos of 7 cases]G Coutant, J P Algayres, J Dubrez, et al.
Journal De Pharmacie De Belgique|August 10, 2011
[Role of the hospital pharmacist in the management of chemotherapy-induced nausea and vomiting]D Breton, V Jandard, A Cauet, et al.
Revue De Pneumologie Clinique|April 19, 2011
[Bifocal lung cancer: the same histology?]F Rivière, A Bonnichon-Py, H Le Floch, et al.
Revue De Pneumologie Clinique|November 20, 2010
[Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study]J Margery, B Milleron, F Vaylet, et al.
Revue Des Maladies Respiratoires|February 1, 2011
[A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)]J Tredaniel, F Mornex, I Barillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2011
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinomaP Hofman, M Ilie, V Hofman, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Revue De Pneumologie Clinique|February 9, 2005
[The risk of thromboembolism in airline passengers]J Margery, A Bonnichon, K Hardy, et al.
Revue De Pneumologie Clinique|November 3, 2009
[Pleuro-pulmonary manifestations disclosing hepatic amoebiasis]A Bonnichon, E Henninot, A Niang, et al.
Revue Des Maladies Respiratoires|February 12, 2010
[Pulmonary malignant melanoma: primary or metastatic?]F Rivière, A Bonnichon-Py, H Le Floch, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 10, 2001
[A revolution in pneumology: positron-emission tomography]F Vaylet, O de Dreuille, P Maszelin, et al.
La Revue De Medecine Interne|January 1, 1996
[Value of video-assisted thoracic surgery in internal medicine. Apropos of 7 cases]G Coutant, J P Algayres, J Dubrez, et al.
Journal De Pharmacie De Belgique|August 10, 2011
[Role of the hospital pharmacist in the management of chemotherapy-induced nausea and vomiting]D Breton, V Jandard, A Cauet, et al.
Revue De Pneumologie Clinique|April 19, 2011
[Bifocal lung cancer: the same histology?]F Rivière, A Bonnichon-Py, H Le Floch, et al.
Revue De Pneumologie Clinique|November 20, 2010
[Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study]J Margery, B Milleron, F Vaylet, et al.
Revue Des Maladies Respiratoires|February 1, 2011
[A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)]J Tredaniel, F Mornex, I Barillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2011
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinomaP Hofman, M Ilie, V Hofman, et al.
Pageof 10